Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Curtiss

Showing results (31-40 of 351) with videos related to

Pageof 36
Sort By:
American Journal of Hospital Pharmacy|August 1, 1984
Reimbursement dilemma regarding home health-care products and servicesF R Curtiss
Journal of Managed Care Pharmacy : JMCP|October 1, 2005
In search of safe and effective oral anticoagulationFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
More evolution of the evidence in asthma disease management--SMART versus GOAL clinical trials debate the cost-benefit of LABA while the value of leukotriene modifiers, particularly montelukast, is uncertainFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable costFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
False-positive versus true-positive drug-drug interactions with warfarinFrederic R Curtiss
American Journal of Hospital Pharmacy|February 1, 1986
HMO, CMP, or PPO?F R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Value for money in disease management of benign prostatic hyperplasiaFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 26, 2005
COPD-whose burden, how large, and what to do about it?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
3-tier drug benefit designs based on sound drug formulary principles will maximize favorable outcomesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Who needs another clinical practice guideline?Frederic R Curtiss
Pageof 36

Showing results (31-40 of 351) with videos related to

Sort By:
Pageof 36
American Journal of Hospital Pharmacy|August 1, 1984
Reimbursement dilemma regarding home health-care products and servicesF R Curtiss
Journal of Managed Care Pharmacy : JMCP|October 1, 2005
In search of safe and effective oral anticoagulationFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
More evolution of the evidence in asthma disease management--SMART versus GOAL clinical trials debate the cost-benefit of LABA while the value of leukotriene modifiers, particularly montelukast, is uncertainFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|June 24, 2006
Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable costFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
False-positive versus true-positive drug-drug interactions with warfarinFrederic R Curtiss
American Journal of Hospital Pharmacy|February 1, 1986
HMO, CMP, or PPO?F R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Value for money in disease management of benign prostatic hyperplasiaFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 26, 2005
COPD-whose burden, how large, and what to do about it?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 15, 2004
3-tier drug benefit designs based on sound drug formulary principles will maximize favorable outcomesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 17, 2004
Who needs another clinical practice guideline?Frederic R Curtiss
Pageof 36